Publications
5808 Results
- Journal / Conference
- Journal of the National Cancer Institute, Dec 31;109(1). pii: djw263
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID28040733
- PMC
- PMC n/a - Review
- Study Number(s)
- S0108, S0213, S0601
Recommendations for clinical trial development in mantle cell lymphoma
- Journal / Conference
- Journal of the National Cancer Institute Dec 31;109(2)
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID28040682
- PMC
- PMC n/a - Review
- Study Number(s)
- S0350, S1108
T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment
- Journal / Conference
- Journal of the National Cancer Institute Dec 16;108(12). pii: djw257. Print 2016 Dec.
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27986884
- PMC
- pending
- Study Number(s)
- S0433, S0515, S9704
Beyond RCHOP: A blueprint for diffuse large B-cell lymphoma research
- Journal / Conference
- Journal of the National Cancer Institute, Dec 31;109(4). pii: djw249
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID28040700
- PMC
- PMC n/a - Review
- Study Number(s)
- S0816
Hodgkin lymphoma: Current status and clinical trial recommendations
- Journal / Conference
- Journal of the National Cancer Institute 2016 Dec 16;108(12). pii: djw250. Print 2016 Dec.
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27986882
General biomarker recommendations for lymphoma
- Journal / Conference
- Blood 128:4651; American Society of Hematology Annual Meeting (December 3-6, 2016, San Hematology Annual Meeting (December 3-6, 2016, SanDiego, CA), poster
- Year
- 2016
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S9704
Autologous transplantation as consolidation for high risk aggressive t-cell non-Hodgkin’s lymphoma: a SWOG S9704 intergroup trial subgroup analysis
- Journal / Conference
- Journal of Clinical Oncology Aug 1;34(22):2602-2609
- Year
- 2016
- Research Committee(s)
- Breast
- PMID
- PMID27138575
- PMC
- PMC5012690
- Study Number(s)
- CTSU/C40503
Phase III trial evaluating letrozole as first-line endocrine therapy with or without bevacizumab for the treatment of postmenopausal women with hormone receptor-positive advanced-stage breast cancer: CALGB 40503 (Alliance)
- Journal / Conference
- Bladder Cancer Apr 27;2(2):165-202
- Year
- 2016
- Research Committee(s)
- Genitourinary
- PMID
- PMID27376138
- PMC
- PMC4927845
- Study Number(s)
- S0337, S0353, S1314, S1602, SWOG-8507
Summary and recommendations from the National Cancer Institute's Clinical Trials planning meeting on novel therapeutics for non-muscle invasive bladder cancer
- Journal / Conference
- American Institute for Cancer Research (Nov 14-16, Bethesda, MD), poster
- Year
- 2016
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- Study Number(s)
- SWOG-9217
A pooled analysis of glycemic index and load and prostate cancer risk
- Journal / Conference
- International Workshop for Waldenstrom's Macroglobulinemia (IWWM-9) (October 5-8, 2016, Amsterdam, Netherlands), LBA, oral, invited talk, session 15
- Year
- 2016
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9003, S9805